An externally controlled trial to indirectly compare tazemetostat plus lenalidomide and rituximab versus lenalidomide and rituximab after at least one prior systemic therapy in patients with refractory and relapsed follicular lymphoma Meeting Abstract
| Authors: | Nastoupil, L. J.; Salles, G.; Leonard, J. P.; Morschhauser, F.; Veazey, K. J.; Perrot, V.; Doban, V.; Bonnet, M.; Sosinsky, A. Z.; Crowley, A.; Lieb, C.; Wang, Z.; Zeldow, B.; Harton, J.; Wang, S.; Garawin, T. |
| Abstract Title: | An externally controlled trial to indirectly compare tazemetostat plus lenalidomide and rituximab versus lenalidomide and rituximab after at least one prior systemic therapy in patients with refractory and relapsed follicular lymphoma |
| Meeting Title: | 65th Annual Meeting of the American Society of Hematology (ASH) |
| Journal Title: | Blood |
| Volume: | 142 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2023 Dec 9-12 |
| Meeting Location: | San Deigo, CA |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2023-11-02 |
| Start Page: | 4410 |
| Language: | English |
| ACCESSION: | WOS:001159740307156 |
| DOI: | 10.1182/blood-2023-181807 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract -- Source: Wos |
